EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cognitive heterogeneity in Parkinson’s disease: A mechanistic view

Marc Carceles-Cordon, Dan Weintraub, Alice S Chen-Plotkin

Neuron · 2023-05 · 111 (10) · 1531-1546

DOI: 10.1016/j.neuron.2023.03.021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuron, 2023-05. Verfasst von Marc Carceles-Cordon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, University of Pennsylvania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive impairment occurs in most individuals with Parkinson's disease (PD), exacting a high toll on patients, their caregivers, and the healthcare system. In this review, we begin by summarizing the current clinical landscape surrounding cognition in PD. We then discuss how cognitive impairment and dementia may develop in PD based on the spread of the pathological protein alpha-synuclein (aSyn) from neurons in brainstem regions to those in the cortical regions of the brain responsible for higher cognitive functions, as first proposed in the Braak hypothesis. We appraise the Braak hypothesis from molecular (conformations of aSyn), cell biological (cell-to-cell spread of pathological aSyn), and organ-level (region-to-region spread of aSyn pathology at the whole brain level) viewpoints. Finally, we argue that individual host factors may be the most poorly understood aspect of this pathological process, accounting for substantial heterogeneity in the pattern and pace of cognitive decline in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSynucleinopathiesHumansalpha-SynucleinBrainCognition

Stichwörter der Autor:innen

Braak hypothesisLewy bodyParkinson’s diseasealpha-synucleincognitiondementiadementia with Lewy bodiesmild cognitive impairmentstrain

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: chenplot@pennmedicine.upenn.edu.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • University of Pennsylvania
  • ACADIA Pharmaceuticals
  • National Institutes of Health
  • Chan Zuckerberg Initiative
  • Otsuka America
  • American Heart Association Inc

Zitieren

APA

Carceles-Cordon, M., Weintraub, D., & Chen-Plotkin, A. S. (2023). Cognitive heterogeneity in Parkinson’s disease: A mechanistic view. Neuron, 111(10), 1531-1546. https://doi.org/10.1016/j.neuron.2023.03.021

Vancouver

Carceles-Cordon M, Weintraub D, Chen-Plotkin AS. Cognitive heterogeneity in Parkinson’s disease: A mechanistic view. Neuron. 2023;111(10):1531-1546. doi:10.1016/j.neuron.2023.03.021

BibTeX
@article{CarcelesCordon2023,
  author = {Carceles-Cordon, Marc and Weintraub, Dan and Chen-Plotkin, Alice S},
  title = {Cognitive heterogeneity in Parkinson’s disease: A mechanistic view},
  journal = {Neuron},
  year = {2023},
  volume = {111},
  number = {10},
  pages = {1531--1546},
  doi = {10.1016/j.neuron.2023.03.021}
}
Kostenlos starten →